IBO
Impact BioMedical
9 hedge funds and large institutions have $76.1K invested in Impact BioMedical in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$30.1K | |
| 2 | +$18K | |
| 3 | +$16.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.16K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.45K |
Top Sellers
| 1 | -$26.7K | |
| 2 | -$25K | |
| 3 | -$3.64K | |
| 4 |
Barclays
London,
United Kingdom
|
-$2K |
| 5 |
Morgan Stanley
New York
|
-$116 |